3 days popular7 days popular1 month popular3 months popular

Fast, accurate new nanoparticle-based sensor system for rapidly screening cancer drugs

Traditional genomic, proteomic and other currently used to characterize drug mechanisms are time-consuming and require , but now researchers led by chemist at the University of Massachusetts Amherst offer a sensor method using that can accurately profile various anti- and their mechanisms in minutes.

[Red, Green and Blue Outputs Provided by Fluorescent Proteins]
UMass Amherst chemists have devised a multi-channel signature-based approach to screening drugs using a gold nanoparticles with red, green and blue outputs provided by fluorescent proteins.
Credit: UMass Amherst


This work was supported by the National Institutes of Health’s Institute for General Medical Sciences and by the National Science Foundation’s Center for Hierarchical Manufacturing at UMass Amherst.

University of Massachusetts at Amherst